These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 319363)

  • 1. Clinical pharmacology of oral antidiabetic agents (first of two parts).
    Shen SW; Bressler R
    N Engl J Med; 1977 Mar; 296(9):493-7. PubMed ID: 319363
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term results with oral hypoglycemic drugs.
    Moss JM; DeLawter DE
    J Am Geriatr Soc; 1973 Feb; 21(2):72-6. PubMed ID: 4688111
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of chronic oral antidiabetic therapy on insulin and glucagon responses to a meal.
    Tsalikian E; Dunphy TW; Bohannon NV; Lorenzi M; Gerich JE; Forsham PH; Kane JP; Karam JH
    Diabetes; 1977 Apr; 26(4):314-21. PubMed ID: 849812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-independent diabetes mellitus.
    Bricker LA; Mintz DH
    Med Clin North Am; 1971 Mar; 55(2):295-304. PubMed ID: 4926053
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of phenformin (DBI) as an adjuvant in oral antidiabetic therapy.
    Goodman JI
    Metabolism; 1965 Nov; 14(11):1153-7. PubMed ID: 5848851
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral sulphonylureas in the management of diabetes.
    Jackson WP
    S Afr Med J; 1971 Jan; 45(5):118-23. PubMed ID: 4925995
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetes mellitus: the thin maturity-onset diabetic.
    Br Med J; 1972 Sep; 3(5828):692-4. PubMed ID: 4631184
    [No Abstract]   [Full Text] [Related]  

  • 8. The use and abuse of oral hypoglycemic agents.
    Sussman KE
    Rocky Mt Med J; 1967 Feb; 64(2):56-9. PubMed ID: 6045352
    [No Abstract]   [Full Text] [Related]  

  • 9. Attempts to delay the progression of chemical diabetes.
    Jimenez JA; Oppermann W; De Lellis RH; Camerini-Dávalos RA
    Adv Metab Disord; 1970; 1():Suppl 1:421+. PubMed ID: 5446909
    [No Abstract]   [Full Text] [Related]  

  • 10. Single and combined drug therapy of sulfonylurea failure.
    Abelove WA; Echenique R
    J Fla Med Assoc; 1969 Apr; 56(4):262-3. PubMed ID: 5776594
    [No Abstract]   [Full Text] [Related]  

  • 11. [CLINICAL OBSERVATIONS DONE WITH ACETOHEXAMIDE IN THE ORAL TREATMENT OF DIABETES MELLITUS IN THE ADULT].
    PAES E; SILVAGOMES FJ; CANAS MA
    Rev Iber Endocrinol; 1964; 11():5-17. PubMed ID: 14134258
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of long-term therapy with oral hypoglycemic agents on the oral glucose tolerance test dynamics in male chemical diabetics.
    Tan MH; Graham CA; Bradley RF; Gleason RE; Soeldner JS
    Diabetes; 1977 Jun; 26(6):561-70. PubMed ID: 324835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral hypoglycaemic drugs.
    Br Med J; 1969 Mar; 1(5647):829-31. PubMed ID: 5774083
    [No Abstract]   [Full Text] [Related]  

  • 14. Status of problem of usage of tolbutamide. Preliminary statements.
    Diabetes; 1970 Jun; 19(6):467-8. PubMed ID: 5467867
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes in the elderly patient.
    Shagan BP
    Med Clin North Am; 1976; 60(6):1191-208. PubMed ID: 790046
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentiation of hypoglycemic effect of chlorpropamide and phenfromin by halofenate.
    Kudzma DJ; Friedberg SJ
    Diabetes; 1977 Apr; 26(4):291-5. PubMed ID: 321288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of diabetes mellitus with oral hypoglycaemic drugs.
    Duncan LJ; Clarke BF; Munro JF
    Curr Med Drugs; 1965 Jun; 5(10):23-32. PubMed ID: 5878054
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of acetohexamide with other sulfonylurea compounds in the treatment of diabetes mellitus.
    Berglund B; Jakobson T
    Acta Med Scand; 1965 Dec; 178(6):735-44. PubMed ID: 5855411
    [No Abstract]   [Full Text] [Related]  

  • 19. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
    GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
    Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
    [No Abstract]   [Full Text] [Related]  

  • 20. ORAL THERAPY FOR DIABETES MELLITUS.
    WILLIAMS RH
    JAMA; 1965 Sep; 193():829-30. PubMed ID: 14329992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.